This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Brad Edwards
Vice President & Lead Scientific/Methodology Advisor
Contact
BradEdwards@westat.comOverview
Brad Edwards is a Vice President and Lead Scientific/Methodology Advisor. He has 4 decades of experience designing and managing large, complex surveys. Edwards leads major studies in health care and aging, fosters innovations in field data collection methods and technologies, and guides policies and procedures for recruiting, training, and managing thousands of field employees throughout the company.
Edwards co-edited several books that illustrate the range of his expertise: Total Survey Error in Practice, Hard-to-Survey Populations, and Survey Methods in Multinational, Multiregional, and Multicultural Contexts.
Education
- BA, Geography and Urban Planning, University of Chicago
Areas of Expertise
Data Collection Data Collector Recruitment, Hiring, and Training Field Management Survey DesignTopics
Complex Surveys-
Expert Interview
Leading with Diverse Ideas: Edwards Shares Vision for JSSAMApril 2024
With 4 decades of designing and managing large, complex surveys, Westat’s Brad Edwards has decided to add another leadership position to his resume by becoming one…
-
Associations between biomarkers of nicotine/tobacco exposure and respiratory symptoms among adults who exclusively smoke cigarettes in the U.S.: Findings from the PATH Study Waves 1–4 (2013–2017)
17,
Addictive Behaviors Reports
January 2023
K.C. Edwards, J.E. Ozga, C. Reyes-Guzman, D. Smith, D. Hatsukami, J.L. Hart, A. Jackson, et al.
DOILink for: Associations between biomarkers of nicotine/tobacco exposure and respiratory symptoms among adults who exclusively smoke cigarettes in the U.S.: Findings from the PATH Study Waves 1–4 (2013–2017) -
Similar survival among all subtypes of mucinous appendiceal adenocarcinoma except the intermediate subtype, which shows an improved survival
30,
Annals of Surgical Oncology
January 2023
P.H. Sugarbaker, D. Chang, J.J. Liang
DOILink for: Similar survival among all subtypes of mucinous appendiceal adenocarcinoma except the intermediate subtype, which shows an improved survival